Robby Markwart
-
- Antibiotic Use and Resistance 7
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 5
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 6
- Endocrinology top 5%
-
- Antimicrobial Resistance in Staphylococcus 5
-
- Sepsis Diagnosis and Treatment 5
- Infective Endocarditis Diagnosis and Management 3
-
- Streptococcal Infections and Treatments 4
-
- Clinical Laboratory Practices and Quality Control 3
- Co-authors
- Tim EckmannsOlaniyi AyobamiNiklas WillrichThomas HarderBenedetta AllegranziCarolin Fleischmann-StruzekFelix ReichertAlessandro Cassini
- Journals
- Antimicrobial Resistance and Infection Control (3 papers)Emerging Microbes & Infections (3 papers)BMJ Open (2 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Robby Markwart
31 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Applied Microbiology and Biotechnology 222
- Molecular Medicine 322
- Clinical Biochemistry 212
- Critical Care and Intensive Care Medicine 115
- Endocrinology 85
Countries citing papers authored by Robby Markwart
This map shows the geographic impact of Robby Markwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby Markwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby Markwart more than expected).
Fields of papers citing papers by Robby Markwart
This network shows the impact of papers produced by Robby Markwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby Markwart. The network helps show where Robby Markwart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robby Markwart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 106 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 29 | |
| 9 | 2021 | 37 | |
| 10 | Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysisbreakdown → | 2021 | 237 |
| 11 | 2021 | 26 | |
| 12 | 2020 | 103 | |
| 13 | 2020 | 48 | |
| 14 | Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysisbreakdown → | 2020 | 223 |
| 15 | 2019 | 121 | |
| 16 | 2019 | 88 | |
| 17 | 2017 | 19 | |
| 18 | 2016 | 28 | |
| 19 | 2016 | 19 | |
| 20 | 2015 | 7 |
About Robby Markwart
Robby Markwart is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Sepsis Diagnosis and Treatment (5 papers), Streptococcal Infections and Treatments (4 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Clinical Laboratory Practices and Quality Control (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (222 citations), Molecular Medicine (322 citations) and Clinical Biochemistry (212 citations). Robby Markwart has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Tim Eckmanns, Olaniyi Ayobami, Niklas Willrich, Thomas Harder, Benedetta Allegranzi, Carolin Fleischmann-Struzek, Felix Reichert, Alessandro Cassini, Ignacio Rubio and Annicka Reuß. Their work appears in journals such as Antimicrobial Resistance and Infection Control, Emerging Microbes & Infections, BMJ Open, Eurosurveillance and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.